drugset / Trial / NCT00470574
Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
Completed
7 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. Giving vaccine therapy together with QS21 may cause a stronger immune response and kill more tumor cells. PURPOSE: This clinical trial is studying the side effects and how well giving vaccine therapy together with QS21 works in treating patients with metastatic breast cancer.
Timeline
- Start
- 2007-03-20
- Primary completion
- 2020-01-24
- Completion
- 2020-01-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QS-21 | Other / unclassified | — | Subcutaneous |
| Subject | sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine | Vaccine | — | Subcutaneous |